Stay updated on Pimavanserin Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 added to the history; revision v3.4.2 removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history and an outdated funding notice was removed; these are minor site maintenance updates that do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status was added. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check48 days agoChange DetectedUI changes include a glossary toggle and color-coded marks for additions and deletions, with the revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check56 days agoChange DetectedThe update adds revision v3.3.4 and removes v3.3.3, affecting only version metadata. No study data, eligibility criteria, results, or records are changed; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry (Revision: v3.3.3) was added to the record history; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.